Neurocrine Biosciences Inc (NBIX) Insider Trading
- $39,032,821.44
- $409,009,080.13
- Aug. 7, 2025
- Kevin Charles Gorman
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
May 7, 2018 | Director | 5,000 | $83.13 | Sell | $415,650.00 | |
May 1, 2018 | CEO | 126,832 | $80.75 | Sell | $10,241,684.00 | |
March 5, 2018 | Insider | 75,873 | $90.00 | Sell | $6,828,570.00 | |
Feb. 15, 2018 | Director | 5,000 | $84.67 | Sell | $423,350.00 | |
Feb. 12, 2018 | Insider | 86,368 | $78.32 | Sell | $6,764,341.76 | |
Feb. 9, 2018 | Insider | 71,775 | $77.98 | Sell | $5,597,014.50 | |
Feb. 6, 2018 | CEO | 105,983 | $80.25 | Sell | $8,505,135.75 | |
Feb. 5, 2018 | Insider | 2,262 | $83.10 | Sell | $187,972.20 | |
Feb. 5, 2018 | Director | 5,000 | $83.08 | Sell | $415,400.00 | |
Jan. 24, 2018 | Director | 9,500 | $90.00 | Sell | $855,000.00 | |
Jan. 16, 2018 | Insider | 1,625 | $79.12 | Sell | $128,570.00 | |
Jan. 16, 2018 | CEO | 3,750 | $78.89 | Sell | $295,837.50 | |
Jan. 3, 2018 | Insider | 1,979 | $79.36 | Sell | $157,053.44 | |
Dec. 28, 2017 | Insider | 15,237 | $75.00 | Sell | $1,142,775.00 | |
Dec. 28, 2017 | Insider | 15,237 | $75.00 | Sell | $1,142,775.00 | |
Dec. 8, 2017 | Insider | 2,955 | $75.00 | Sell | $221,625.00 | |
Dec. 4, 2017 | Insider | 6,279 | $75.04 | Sell | $471,176.16 | |
Dec. 1, 2017 | Director | 10,000 | $72.92 | Sell | $729,200.00 | |
Nov. 15, 2017 | Insider | 9,900 | $73.05 | Sell | $723,195.00 | |
Nov. 8, 2017 | Insider | 30,000 | $74.58 | Sell | $2,237,400.00 | |
Nov. 2, 2017 | Insider | 24,818 | $71.05 | Sell | $1,763,318.90 | |
Oct. 2, 2017 | Insider | 6,925 | $61.04 | Sell | $422,702.00 | |
Sept. 6, 2017 | Insider | 26,250 | $60.00 | Sell | $1,575,000.00 | |
Sept. 5, 2017 | Insider | 52,817 | $57.50 | Sell | $3,036,977.50 | |
Aug. 9, 2017 | Insider | 15,354 | $55.00 | Sell | $844,470.00 | |
Aug. 4, 2017 | Insider | 22,500 | $50.00 | Sell | $1,125,000.00 | |
July 27, 2017 | Insider | 8,734 | $50.00 | Sell | $436,700.00 | |
May 23, 2017 | Insider | 10,000 | $53.39 | Sell | $533,900.00 | |
May 19, 2017 | Insider | 9,960 | $53.63 | Sell | $534,154.80 | |
May 5, 2017 | Director | 5,000 | $53.98 | Sell | $269,900.00 | |
May 2, 2017 | CEO | 21,739 | $53.23 | Sell | $1,157,166.97 | |
May 2, 2017 | Insider | 10,000 | $55.00 | Sell | $550,000.00 | |
May 1, 2017 | Insider | 15,000 | $54.00 | Sell | $810,000.00 | |
April 12, 2017 | CEO | 19,596 | $50.42 | Sell | $988,030.32 | |
April 12, 2017 | Insider | 13,065 | $50.42 | Sell | $658,737.30 | |
Feb. 7, 2017 | Insider | 116 | $44.61 | Sell | $5,174.76 | |
Feb. 6, 2017 | Insider | 727 | $43.13 | Sell | $31,355.51 | |
Feb. 6, 2017 | CEO | 3,010 | $43.18 | Sell | $129,971.80 | |
Feb. 6, 2017 | CFO | 963 | $43.14 | Sell | $41,543.82 | |
Feb. 3, 2017 | CEO | 3,125 | $42.55 | Sell | $132,968.75 | |
Feb. 3, 2017 | Insider | 1,500 | $42.50 | Sell | $63,750.00 | |
Feb. 1, 2017 | Director | 10,750 | $42.28 | Sell | $454,510.00 | |
Jan. 17, 2017 | CEO | 3,750 | $40.65 | Sell | $152,437.50 | |
Jan. 17, 2017 | Insider | 1,625 | $40.63 | Sell | $66,023.75 | |
Jan. 17, 2017 | CFO | 1,750 | $40.65 | Sell | $71,137.50 | |
Jan. 10, 2017 | Insider | 1,750 | $43.35 | Sell | $75,862.50 | |
Jan. 10, 2017 | CEO | 3,750 | $43.28 | Sell | $162,300.00 | |
Nov. 15, 2016 | Insider | 25,000 | $52.84 | Sell | $1,321,000.00 | |
Sept. 1, 2016 | Insider | 9,000 | $50.00 | Sell | $450,000.00 | |
Aug. 15, 2016 | Insider | 12,500 | $48.73 | Sell | $609,125.00 |
Insiders are both buying and selling Neurocrine Biosciences Inc stock.
The insider traders at Neurocrine Biosciences Inc are: Kevin Charles Gorman, Darin Lippoldt, Gary A Lyons, Haig P Bozigian, Dimitri E Grigoriadis, Matt Abernethy, Christopher Flint Obrien, Eiry Roberts, Eric Benevich, Timothy P Coughlin, Kyle Gano, Ingrid Delaet, Julie Cooke, Malcolm Lloyd-Smith, William H Rastetter, Richard F Pops, David W Boyer, W Thomas Mitchell, Jude Onyia, Stephen A Sherwin, Timothy Coughlin, Corinne H Nevinny, Haig Bozigian, Dimitri Grigoriadis, Neurocrine Biosciences Inc, Shalini Sharp, Leslie V. Norwalk, Dimitri E. Grigoriadis, Gary A. Lyons, Haig P. Bozigian, and George J. Morrow
The most active insider trader at Neurocrine Biosciences Inc is Kevin Charles Gorman with 47 trades.
Kevin Charles Gorman has sold the most Neurocrine Biosciences Inc stock with a total value of $149,736,416.50.
Neurocrine Biosciences Inc has bought the most Neurocrine Biosciences Inc stock with a total value of $78,065,642.88.
The most recent insider trade for Neurocrine Biosciences Inc was on Aug. 7, 2025.
The single biggest insider buy for Neurocrine Biosciences Inc was from Neurocrine Biosciences Inc with a total value of $39,032,821.44 on Feb. 23, 2023.
The single biggest insider sell for Neurocrine Biosciences Inc was from Kevin Charles Gorman with a total value of $33,975,315.00 on Jan. 8, 2021.